Documentary Looks at Operation Whitecoat

Kimberly Luste Maran interviewed Colonel Randall Larsen, USAF (Ret.) about his documentary Operation Whitecoat (Filmmaker talks about documentary on Adventist volunteers in Army's "Operation Whitecoat",, 21 June 2016). The article begins:

"Operation Whitecoat" is a documentary that tells the story of more than 2,300 Adventist, noncombatant conscientious objectors who volunteered for biodefense research studies from 1954-1973. These patriots are described as showing extraordinary commitment to their religious principles and great courage to participate in tests that produced outcomes reaching far beyond Army biodefense.
Through 151 medical studies during 19 years, a vast amount of data was gathered on naturally-occurring diseases. Thought the project is not without some controversy, thirteen important vaccines still used around the world were developed and tested for safety and efficacy during Operation Whitecoat. Vaccines still in use today include Yellow Fever, Hepatitis A, Plague, Tularemia, Typhus, Rift Valley Fever, Q Fever, Venezuelan Equine Encephalitis, Western Equine Encephalitis, Eastern Equine Encephalitis, Rocky Mountain Spotted Fever, Chikungunya, and Adenovirus.

Maran and Larsen wrap-up the interview with the following two exchanges:

Who do you hope watches this, and why?
I made the film as a tribute to the commitment, courage, and contributions of the Whitecoats. The Whitecoats and their families are the primary audience. We also hope that the members of the Seventh-day Adventist Church will learn more about these extraordinary men, and hope that the church will use the film as a teaching tool to facilitate discussion on non-combatant conscientious objectors, ethics, and service to one's community and country. We eventually hope to take this inspiring story to a broad audience who have not yet heard about Whitecoats, and who have little knowledge of the Adventist Church.
How can people watch the documentary film?
This film is available for purchase; for more information and to watch a trailer, go to:

To read the complete interview, visit